000 04487nam a22004455i 4500
001 978-1-4614-8845-3
003 DE-He213
005 20140220082503.0
007 cr nn 008mamaa
008 131008s2014 xxu| s |||| 0|eng d
020 _a9781461488453
_9978-1-4614-8845-3
024 7 _a10.1007/978-1-4614-8845-3
_2doi
050 4 _aRA1-1270
072 7 _aMBN
_2bicssc
072 7 _aMED078000
_2bisacsh
082 0 4 _a613
_223
082 0 4 _a614
_223
100 1 _aEaton, Lisa A.
_eeditor.
245 1 0 _aBiomedical Advances in HIV Prevention
_h[electronic resource] :
_bSocial and Behavioral Perspectives /
_cedited by Lisa A. Eaton, Seth C. Kalichman.
264 1 _aNew York, NY :
_bSpringer New York :
_bImprint: Springer,
_c2014.
300 _aXV, 269 p. 13 illus.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aPart I. Advances in HIV Prevention Technologies -- Chapter 1: Advances, Promises, and Challenges in HIV Prevention -- Chapter 2: Pre-Exposure Prophylaxis -- Chapter 3: Prevention Services with Persons Living with HIV -- Chapter 4: Advocating for Rectal Microbicides and Safe Lubricants -- Part II. Behavioral Challenges and Opportunities -- Chapter 5: Adherence to HIV Treatment as Prevention and Pre-Exposure Prophylaxis -- Chapter 6: Risk Compensation in Response to HIV Prevention -- Chapter 7: Mental Health and Substance Use in the Scale Up of HIV Prevention -- Chapter 8: Substance Use Treatment in the Era of New HIV Prevention Technologies -- Part III. Global Perspectives -- Chapter 9: Revolution or evolution? What can approaches based on the use of antiretroviral drugs contribute to HIV prevention in gay communities in high-income countries? -- Chapter 10: Implementing Biomedical HIV Prevention Advances in Uganda -- Chapter 11: Implementing Biomedical HIV Prevention Advances in Thailand -- Chapter 12: Implementing Biomedical HIV Prevention Advances in Ecuador and Peru.
520 _aBiomedical Advances in HIV Prevention: Social and Behavioral Perspectives   Lisa A. Eaton and Seth C. Kalichman, editors     Three decades into the epidemic, a great deal is known about HIV and its transmission, more people are living with the disease, and the virus is no longer seen as a death sentence. But new people continue to be infected with HIV each year, making prevention strategies that are medically effective and behaviorally engaging as urgent a priority as ever.   Biomedical Advances in HIV Prevention: Social and Behavioral Perspectives assembles the latest improvements, barriers to implementation, and possibilities for--and challenges to--future progress. Innovations such as pre-exposure prophylaxis (antiretroviral regimens for the high-risk uninfected) and treatment as prevention (early use of ART to reduce infectiousness of new patients) are examined, as are current findings on ongoing prevention and treatment concerns. Contributors illuminate the complex realities entailing adherence, pointing out technological, behavioral, and cultural roadblocks as well as opportunities to significantly reduce infection rates. Detailed up-to-the-minute coverage includes:   Prevention services for persons living with HIV Adherence to HIV treatment as prevention and pre-exposure prophylaxis Advocating for rectal microbicides and safe lubricants Mental health and substance use in the scale-up of HIV prevention Risk compensation in response to HIV prevention Implementing biomedical HIV prevention advances: reports from South Africa, Uganda, Australia, Thailand, United States, Ecuador, and Peru   Researchers, practitioners, and policy makers working in the fields of HIV/AIDS and public health will look toward Biomedical Advances in HIV Prevention: Social and Behavioral Perspectives as both a means for developing and assessing current programs and a blueprint for the next generation of prevention efforts.
650 0 _aMedicine.
650 0 _aPublic health.
650 1 4 _aMedicine & Public Health.
650 2 4 _aPublic Health.
650 2 4 _aHealth Promotion and Disease Prevention.
700 1 _aKalichman, Seth C.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9781461488446
856 4 0 _uhttp://dx.doi.org/10.1007/978-1-4614-8845-3
912 _aZDB-2-SME
999 _c92261
_d92261